Medical Patent Broker 500 px Logo with white letters and transparent backgroundMedical Patent Broker 500 px Logo with white letters and transparent backgroundMedical Patent Broker 500 px Logo with white letters and transparent backgroundMedical Patent Broker 500 px Logo with white letters and transparent background
  • HOME
  • FAQs
  • BLOG
  • SUBMIT LISTING/OFFER
  • EXPERTS DIRECTORY
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Patents
  • All
  • 505(b)(2)
  • alternative path
  • board of directors
  • Business strategy
  • cdc
  • CDC impact
  • CEO
  • Clinical Trials
  • CMS
  • deadlines
  • escrow
  • extending a patent
  • FDA
  • FDA Approval
  • financial impact
  • Grants
  • history
  • Hold
  • institutional path
  • invention
  • IRS
  • Juggling
  • License
  • Marketing
  • Medicaid
  • medical patent
  • Medicare
  • orphan drugs
  • Patent
  • Patent Maestro
  • Patent Strategy
  • patents
  • phase III
  • Phase IV
  • problems
  • Process
  • Remaining Patent Term
  • risk management
  • ROI
  • Sell
  • stock split
  • stocks
  • Strategy
  • tax
  • time
  • Timing
  • Transfers
  • All
  • admin
  • Kenneth Pearce
August 3, 2026
Waylaid in Phase III_ What to Do When the FDA Panel Questions Your Foundation

Waylaid in Phase III: What to Do When the FDA Panel Questions Your Foundation

Do you like it?
Read more
April 29, 2026
The Trifecta Medical Patent Transfer

The Trifecta Medical Patent Transfer: All Three Have To Match For A Win

Do you like it?
Read more

Patent Maestro® – Orchestrating Technology To The Patient℠

©2024-2026 Medical Patents Broker, Inc. | Sitemap | Website by Cool Jazz, LLC

Privacy Policy | Terms of Service | Directory Disclaimer & Terms | Cookie Policy | Contact